Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 37, Issue 10, Pages 2878-2886Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2013.10.010
Keywords
APOE epsilon 2; Alzheimer's disease; Cognitive health; Longevity; Neuroprotection
Categories
Funding
- University of Oxford Clarendon scholarship
- Alzheimer's Research UK studentship [1077089]
- Rhodes scholarship
- National Institute for Health Research (NIHR), UK as part of the Oxford Biomedical Research Centre (BRC)
- Alzheimers Research UK [ART-PhD2010-4] Funding Source: researchfish
Ask authors/readers for more resources
Ongoing efforts to improve survival, and enhance quality of life have led biomedical research to focus on disease and the mechanisms that increase risk for disease. The other side of that coin may be as important, i.e. examining the protective factors that allow some individuals to enjoy long, healthy lives. One of the best examples of a gene that positively influences cognitive health is the apolipoprotein (APOE) epsilon 2 allele. The APOE epsilon 4 allele is a well-established risk factor for Alzheimer's disease (AD) and has thus dominated the APOE literature, with the putative protective role of epsilon 2 receiving little attention. This review describes the effects of APOE epsilon 2 on the structure and function of the brain. With a focus on neurodegeneration, we discuss evidence for APOE epsilon 2's protective effects, explore some key mechanisms through which this protection may be conferred, and address a few inconsistencies in the literature. Understanding the mechanisms that underlie the association between APOE epsilon 2, cognition and longevity may provide new targets for research on promoting life-long health. (C) 2013 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available